(Q42639500)

4 November 2017

title

Galantamine treatment in outpatients with mild Alzheimer's disease (English)

1 reference

4 November 2017

0 references

U Richarz

1

1 reference

4 November 2017

M Gaudig

series ordinal

2

1 reference

4 November 2017

K Rettig

series ordinal

3

1 reference

4 November 2017

B Schauble

series ordinal

4

1 reference

4 November 2017

language of work or name

English

0 references

publication date

25 January 2014

1 reference

Acta Neurologica Scandinavica

4 November 2017

published in

1 reference

4 November 2017

volume

129

1 reference

4 November 2017

issue

6

1 reference

4 November 2017

page(s)

382-392

1 reference

2012: A watershed year for Alzheimer's disease research.

4 November 2017

cites work

1 reference

A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

21 January 2018

1 reference

Effects of galantamine versus donepezil on sleep in patients with mild to moderate Alzheimer disease and their caregivers: a double-blind, head-to-head, randomized pilot study.

21 January 2018

1 reference

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD.

21 January 2018

1 reference

Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer's disease: systematic review and economic model.

21 January 2018

1 reference

Long-term response to galantamine in relation to short-term efficacy data: pooled analysis in patients with mild to moderate Alzheimer's disease

21 January 2018

1 reference

Galantamine and behavior in Alzheimer disease: analysis of four trials

21 January 2018

1 reference

EFNS guidelines for the diagnosis and management of Alzheimer's disease.

21 January 2018

1 reference

Aligning the evidence with practice: NICE guidelines for drug treatment of Alzheimer's disease.

21 January 2018

1 reference

Galantamine treatment in Alzheimer's disease: response and long-term outcome in a routine clinical setting

21 January 2018

1 reference

Cognitive performance in patients with Alzheimer's disease receiving cholinesterase inhibitors for up to 5 years

21 January 2018

1 reference

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

A new rating scale for Alzheimer's disease.

21 January 2018

1 reference

The Bayer Activities of Daily Living Scale (B-ADL).

21 January 2018

1 reference

The Bayer-Activities of Daily Living Scale (B-ADL): results from a validation study in three European countries.

21 January 2018

1 reference

The Bayer: Activities of Daily Living Scale (B-ADL) in the differentiation between mild to moderate dementia and normal aging.

21 January 2018

1 reference

Bayer-activities of daily living scale in mild and moderate dementia of the Alzheimer type

21 January 2018

1 reference

The Neuropsychiatric Inventory: assessing psychopathology in dementia patients

21 January 2018

1 reference

Strategies for analysing behavioural data in clinical trials involving patients with Alzheimer's disease

21 January 2018

1 reference

A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration.

21 January 2018

1 reference

Critical evaluation of self-rated quality of life in mild cognitive impairment and Alzheimer's disease--further evidence for the impact of anosognosia and global cognitive impairment.

21 January 2018

1 reference

Appraising the need for care in Alzheimer's disease

21 January 2018

1 reference

Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis

21 January 2018

1 reference

Psychiatric diagnosis and clinical trial completion rates: analysis of the FDA SBA reports

21 January 2018

1 reference

Prognostic factors affecting long-term retention of topiramate in patients with chronic epilepsy.

21 January 2018

1 reference

Last-observation-carried-forward imputation method in clinical efficacy trials: review of 352 antidepressant studies

21 January 2018

1 reference

The prevention and treatment of missing data in clinical trials

21 January 2018

1 reference

Analyzing incomplete longitudinal clinical trial data

21 January 2018

1 reference

Does analysis using "last observation carried forward" introduce bias in dementia research?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/ANE.12195

1 reference

4 November 2017

1 reference